Policy statement. Recombinant DNA research.
D004274:DNA, Recombinant; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004926:Escherichia coli / Q000378:metabolism*; D006801:Humans; D007328:Insulin / Q000096:biosynthesis* / Q000627:therapeutic use; D009316:National Institutes of Health (U.S.); D012106:Research; D012955:Societies, Medical; D014481:United States
D004274:DNA, Recombinant; D007328:Insulin